We are live on ! Find out more
TPST icon

Tempest Therapeutics
TPST

35 hedge funds and large institutions have $75.6M invested in Tempest Therapeutics in 2013 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 11 increasing their positions, 3 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

267% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 3

175% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 4

21% more funds holding

Funds holding: 29 → 35 (+6)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

11% less capital invested

Capital invested by funds: $85.1M → $75.6M (-$9.48M)

Holders
35
Holders Change
+6
Holders Change %
+20.69%
% of All Funds
1.13%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
11
Increased
11
Reduced
3
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
JHIU
Janus Henderson Investors US
Colorado
+$5.36M
2
JP Morgan Chase
JP Morgan Chase
New York
+$4.22M
3
Franklin Resources
Franklin Resources
California
+$3.69M
4
SM
Sabby Management
Florida
+$1.95M
5
Northern Trust
Northern Trust
Illinois
+$958K

Top Sellers

Rank Fund Capital Flow
1
BCM
BBT Capital Management
Texas
-$1.67M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$191K
3
Bank of America
Bank of America
North Carolina
-$177K
4
Morgan Stanley
Morgan Stanley
New York
-$150K
5
FTUS
Flow Traders U.S.
New York
-$106K
Name Holding Trade Value Shares
Change 		Change in
Stake
DVC
1
Deer VII & Co
New York
$22.2M – – –
Fidelity Investments
2
Fidelity Investments
Massachusetts
$13.6M +$639K +18 +4%
JHIU
3
Janus Henderson Investors US
Colorado
$10.4M +$5.36M +151 +73%
DM
4
Deerfield Management
New York
$6.02M +$639K +18 +9%
BCM
5
BBT Capital Management
Texas
$5.25M -$1.67M -47 -21%
JP Morgan Chase
6
JP Morgan Chase
New York
$3.45M +$4.22M +119 New
Franklin Resources
7
Franklin Resources
California
$3.03M +$3.69M +104 New
BFA
8
BlackRock Fund Advisors
California
$2.52M +$355K +10 +13%
SM
9
Sabby Management
Florida
$1.6M +$1.95M +55 New
Northern Trust
10
Northern Trust
Illinois
$1.07M +$958K +27 +270%
BIT
11
BlackRock Institutional Trust
California
$1.05M +$248K +7 +24%
Vanguard Group
12
Vanguard Group
Pennsylvania
$1.03M – – –
State Street
13
State Street
Massachusetts
$533K +$319K +9 +100%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$462K – – –
TCIM
15
TIAA CREF Investment Management
New York
$422K -$35.5K -1 -6%
AWMDMG
16
Austin W. Marxe & David M. Greenhouse
New York
$297K +$355K +10 New
FTUS
17
Flow Traders U.S.
New York
$257K -$106K -3 -25%
Bank of New York Mellon
18
Bank of New York Mellon
New York
$251K – – –
BCM
19
Bridgeway Capital Management
Texas
$248K +$319K +9 New
BIM
20
BlackRock Investment Management
Delaware
$245K – – –
Jane Street
21
Jane Street
New York
$195K +$248K +7 New
PAM
22
Panagora Asset Management
Massachusetts
$192K +$106K +3 +75%
CCA
23
Catalyst Capital Advisors
New York
$178K +$213K +6 New
California State Teachers Retirement System (CalSTRS)
24
California State Teachers Retirement System (CalSTRS)
California
$159K – – –
Deutsche Bank
25
Deutsche Bank
Germany
$146K +$106K +3 +150%
1
2

TPST Hedge Fund Activity: Q3 2013 in Review

35 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Tempest Therapeutics (TPST) for Q3 2013, worth a combined $75.6M — down 11% from $85.1M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new TPST positions and 4 closed out — a net gain of 7 holders — while 11 added to existing stakes and 3 trimmed.

The largest buyer was Janus Henderson Investors US, adding an estimated $5.36M. The largest seller was BBT Capital Management, cutting an estimated $1.67M.

  • 35 institutional investors held Tempest Therapeutics (TPST) as of Q3 2013, up from 29 in Q2 2013.
  • Funds reported $75.6M of Tempest Therapeutics stock for Q3 2013, down 11% quarter-over-quarter.
  • 11 funds opened new Tempest Therapeutics positions in Q3 2013 and 4 closed out, a net change of +7 holders.
  • The largest Tempest Therapeutics buyer in Q3 2013 was Janus Henderson Investors US, an estimated $5.36M added.
  • The largest Tempest Therapeutics seller in Q3 2013 was BBT Capital Management, an estimated $1.67M sold.

Based on aggregated 13F filings for Q3 2013.